Digital Supportive Care Awareness & Navigation

NCT03628794 | Completed

• 1 other identifier: Pro00092123
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

To pilot test the feasibility, usability, and preliminary efficacy of the D-SCAN mobile application in cancer patients and caregivers at Duke.

Conditions

Supportive Care

Outcome Measures

Primary Outcomes (3)

• Number of enrolled patients complete at least 3 of the 12 symptom surveys over the study duration

  12 weeks

• Number of patients who complete the exit survey

  12 weeks

• Number of patients who return the phone

  12 weeks

Secondary Outcomes (5)

• Frequency of use

  12 weeks

• Duration of use

  12 weeks

• Session Length

  12 weeks

• Number of content views

  12 weeks

• Number of actions taken

  12 weeks

Study Arms (2)

Intervention

OTHER

Subjects in the intervention group will receive the D-SCAN mobile application

Device: D-SCAN

Control

OTHER

Subjects randomized into the control group will receive standard of care which includes the routine provision of information about supportive care services by nurses and other staff in the DCI clinics, as part of the standard nurse-driven distress screening and management process

Device: D-SCAN

Interventions

D-SCAN DEVICE

Subjects will receive a digital patient navigator service in the form of a mobile application ("app"), which has been designed at Duke, with feedback from Duke Cancer Institute (DCI) patients, caregivers and clinicians. Its purpose is to facilitate awareness of available Cancer Patient Support Program (CPSP) services at Duke, and to also help patients recognize their unmet symptom management needs. Subjects receiving the D-SCAN mobile app will also complete a survey every week within the app. The first 15 patients and 5 caregivers randomized into the intervention arm (those receiving the app) will also be asked to participate in a qualitative interview assessment at week 12, +/- 3 weeks

Control; Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients who are at least age 18
• Patients who have the capacity to give consent
• Patients with advanced cancer who have initiated treatment at the DCI in the last 12 weeks
• Caregivers over the age of 18 caring for either enrolled or not enrolled patients with advanced cancer who have initiated treatment at the DCI in the last 12 weeks

You may not qualify if:

• Patients who are too ill to participate (per clinician discretion)
• Patients not able to read or understand English

Sponsors & Collaborators

• Duke University: lead
• AstraZeneca: collaborator

Study Sites (1)

Duke University Cancer Center

Durham, North Carolina, 27705, United States

Location

Related Publications (1)

• Merz A, Mohamed A, Corbett C, Herring K, Hildenbrand J, Locke SC, Patierno S, Troy J, Wolf S, Zafar SY, Chilcott J, Higgins A, Manassei H, McCoy C, Buckingham TL, LeBlanc TW. A single-site pilot feasibility randomized trial of a supportive care mobile application intervention for patients with advanced cancer and caregivers. Support Care Cancer. 2022 Oct;30(10):7853-7861. doi: 10.1007/s00520-022-07224-x. Epub 2022 Jun 20.

  PMID: 35718794 DERIVED

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 10, 2018
• First Posted: August 14, 2018
• Study Start: October 25, 2018
• Primary Completion: March 1, 2019
• Study Completion: March 1, 2019
• Last Updated: July 18, 2019

Record last verified: 2019-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)